BACKGROUND AND AIMS: Prospective information on the use and yield of surveillance colonoscopy is limited. We examined the use and yield of surveillance colonoscopy among participants in the Polyp Prevention Trial (PPT) after the 4-year dietary intervention trial ended. METHODS: We followed a cohort of 1297 participants. We calculated the cumulative probability of posttrial colonoscopy and investigated the yield and predictive factors for adenoma and advanced adenoma recurrence over a mean time of 5.9 years. RESULTS: Seven-hundred seventy-four subjects (59.7%) had a repeat colonoscopy. Among 431 subjects with low-risk adenomas (1-2 nonadvanced adenomas) at baseline and no adenoma recurrence at the end of the PPT (lowest-risk category), 30.3% underwent a repeat colonoscopy within 4 years. Among 55 subjects who had high-risk adenomas (advanced adenoma and/or > or =3 nonadvanced adenomas) at baseline and again at the final PPT colonoscopy (highest-risk category), 41.3% had a colonoscopy within 3 years and 63.5% had an examination within 5 years. The cumulative yield of advanced adenoma through 6 years was 3.6% for the lowest-risk category, 38.9% for the highest-risk category, and ranged from 6.6% to 13.8% for intermediate-risk categories. An advanced adenoma at the final PPT colonoscopy was associated significantly with an advanced adenoma recurrence during surveillance (hazard ratio, 6.2; 95% confidence interval, 2.5-15.4). CONCLUSIONS: Surveillance colonoscopy was overused for low-risk subjects and underused for high-risk subjects. Advanced adenoma yield corresponded with the adenoma risk category. Resource consumption can be better managed by aligning use with the risk of adenoma recurrence.
BACKGROUND AND AIMS: Prospective information on the use and yield of surveillance colonoscopy is limited. We examined the use and yield of surveillance colonoscopy among participants in the Polyp Prevention Trial (PPT) after the 4-year dietary intervention trial ended. METHODS: We followed a cohort of 1297 participants. We calculated the cumulative probability of posttrial colonoscopy and investigated the yield and predictive factors for adenoma and advanced adenoma recurrence over a mean time of 5.9 years. RESULTS: Seven-hundred seventy-four subjects (59.7%) had a repeat colonoscopy. Among 431 subjects with low-risk adenomas (1-2 nonadvanced adenomas) at baseline and no adenoma recurrence at the end of the PPT (lowest-risk category), 30.3% underwent a repeat colonoscopy within 4 years. Among 55 subjects who had high-risk adenomas (advanced adenoma and/or > or =3 nonadvanced adenomas) at baseline and again at the final PPT colonoscopy (highest-risk category), 41.3% had a colonoscopy within 3 years and 63.5% had an examination within 5 years. The cumulative yield of advanced adenoma through 6 years was 3.6% for the lowest-risk category, 38.9% for the highest-risk category, and ranged from 6.6% to 13.8% for intermediate-risk categories. An advanced adenoma at the final PPT colonoscopy was associated significantly with an advanced adenoma recurrence during surveillance (hazard ratio, 6.2; 95% confidence interval, 2.5-15.4). CONCLUSIONS: Surveillance colonoscopy was overused for low-risk subjects and underused for high-risk subjects. Advanced adenoma yield corresponded with the adenoma risk category. Resource consumption can be better managed by aligning use with the risk of adenoma recurrence.
Authors: Todd H Baron; Brenda D Kimery; Darius Sorbi; Linda C Gorkis; Jonathan A Leighton; David E Fleischer Journal: Clin Gastroenterol Hepatol Date: 2004-02 Impact factor: 11.382
Authors: S J Winawer; R H Fletcher; L Miller; F Godlee; M H Stolar; C D Mulrow; S H Woolf; S N Glick; T G Ganiats; J H Bond; L Rosen; J G Zapka; S J Olsen; F M Giardiello; J E Sisk; R Van Antwerp; C Brown-Davis; D A Marciniak; R J Mayer Journal: Gastroenterology Date: 1997-02 Impact factor: 22.682
Authors: Rebecca L Sedjo; Tim Byers; Theodore R Levin; Steven M Haffner; Mohammed F Saad; Janet A Tooze; Ralph B D'Agostino Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-03 Impact factor: 4.254
Authors: E Lanza; A Schatzkin; R Ballard-Barbash; D Corle; C Clifford; E Paskett; D Hayes; E Bote; B Caan; M Shike; J Weissfeld; M Slattery; D Mateski; C Daston; D C Clifford Journal: Cancer Epidemiol Biomarkers Prev Date: 1996-05 Impact factor: 4.254
Authors: Sidney J Winawer; Ann G Zauber; Robert H Fletcher; Jonathon S Stillman; Michael J O'Brien; Bernard Levin; Robert A Smith; David A Lieberman; Randall W Burt; Theodore R Levin; John H Bond; Durado Brooks; Tim Byers; Neil Hyman; Lynne Kirk; Alan Thorson; Clifford Simmang; David Johnson; Douglas K Rex Journal: Gastroenterology Date: 2006-05 Impact factor: 22.682
Authors: Vikram Boolchand; Gregory Olds; Joseph Singh; Pankaj Singh; Amitabh Chak; Gregory S Cooper Journal: Ann Intern Med Date: 2006-11-07 Impact factor: 25.391
Authors: Elaine Lanza; Binbing Yu; Gwen Murphy; Paul S Albert; Bette Caan; James R Marshall; Peter Lance; Electra D Paskett; Joel Weissfeld; Marty Slattery; Randall Burt; Frank Iber; Moshe Shike; James W Kikendall; Brenda K Brewer; Arthur Schatzkin Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-09 Impact factor: 4.254
Authors: Elizabeth T Jacobs; María Elena Martínez; David S Alberts; Ruiyun Jiang; Peter Lance; Kimberly A Lowe; Patricia A Thompson Journal: Clin Gastroenterol Hepatol Date: 2007-06-05 Impact factor: 11.382
Authors: S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish Journal: N Engl J Med Date: 1993-12-30 Impact factor: 91.245
Authors: Gregory S Cooper; Tzuyung D Kou; Jill S Barnholtz Sloan; Siran M Koroukian; Mark D Schluchter Journal: Cancer Date: 2013-02-21 Impact factor: 6.860
Authors: Joseph C Anderson; John A Baron; Dennis J Ahnen; Elizabeth L Barry; Roberd M Bostick; Carol A Burke; Robert S Bresalier; Timothy R Church; Bernard F Cole; Marcia Cruz-Correa; Adam S Kim; Leila A Mott; Robert S Sandler; Douglas J Robertson Journal: Gastroenterology Date: 2017-02-20 Impact factor: 22.682
Authors: Douglas J Robertson; Carol A Burke; H Gilbert Welch; Robert W Haile; Robert S Sandler; E Robert Greenberg; Dennis J Ahnen; Robert S Bresalier; Richard I Rothstein; Bernard Cole; Leila A Mott; John A Baron Journal: Ann Intern Med Date: 2009-07-21 Impact factor: 25.391
Authors: Djenaba A Joseph; Reinier G S Meester; Ann G Zauber; Diane L Manninen; Linda Winges; Fred B Dong; Brandy Peaker; Marjolein van Ballegooijen Journal: Cancer Date: 2016-05-20 Impact factor: 6.860